BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 106 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,286,000 | -72.4% | 50,000 | -85.9% | 1.17% | -78.9% |
Q2 2019 | $15,546,000 | +18.0% | 355,000 | +38.7% | 5.53% | -11.8% |
Q1 2019 | $13,177,000 | +47.7% | 256,000 | +6.1% | 6.27% | -7.9% |
Q4 2018 | $8,924,000 | +27.6% | 241,300 | +29.5% | 6.81% | +172.7% |
Q3 2018 | $6,995,000 | -17.2% | 186,300 | -12.9% | 2.50% | +66.0% |
Q2 2018 | $8,449,000 | – | 213,800 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |